MENU
 
  Sunday, February 12, 2012
Market Day
Company News
Finance
Home
Health
Dieting
Gifts
Software
Insurance
Recent

Bristol Myers Squibb News
DuPont Co to auction vehicle paint unit; expects $4 bn news
domain-BThe sale would be the Wilmington, Delaware-based company's third largest asset disposal since 2001, after it sold most of its pharmaceuticals business to Bristol-Myers Squibb for $7.8 billion and its fibres unit in 2004 to Koch Industries for $4.2 ...

CRL on Dapagliflozin May Require New Clinical Trials
FDA news (subscription)Bristol-Myers Squibb (BMS) and AstraZeneca (AZ) have received a complete response letter for diabetes drug dapagliflozin. The agency is requesting more data from ongoing Phase III trials to help clarify the risk-benefit profile, and the companies say ...

First Solar (FSLR) Shares Drop on Downgrade and Loan Issues
IRAOver the past decade, David has taught English in the United States Embassy in Mexico City, and has also been a translation consultant for MasterCard, Kimberly-Clark, AeroMexico, Bristol-Myers Squibb and PepsiCo. Read other articles by David Huber on ...

Dow Jones (DJIA) Retreats 1 Percent on Greek Concerns
IRAOver the past decade, David has taught English in the United States Embassy in Mexico City, and has also been a translation consultant for MasterCard, Kimberly-Clark, AeroMexico, Bristol-Myers Squibb and PepsiCo. Read other articles by David Huber on ...

Apotex pays Bristol, Sanofi damages over Plavix
FederalNewsRadio.comApotex Corp., Canada's biggest drugmaker has paid Bristol-Myers Squibb Co. and Sanofi SA more than $442 million to end a decade-long patent infringement case over blockbuster blood thinner Plavix, the world's second-best-selling drug.

Summary Box: $445M ends decade battle over Plavix
FederalNewsRadio.comBy AP (AP) - FINALLY OVER: A decadelong patent infringement battle over blood thinner Plavix ends with generic drugmaker Apotex Corp. paying about $445 million to Bristol-Myers Squibb and Sanofi. They jointly sell the world's second-best-selling drug.

From Earlier: Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent ...
BenzingaBy Eddie Staley Sanofi (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that Apotex has made payment in the amount of $442209362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix® (clopidogrel ...



Copyright © 2004-2011 Market-Day.net
All rights reserved.